Athersys (ATHXQ)
OTHER OTC:ATHXQ
US Market
Holding ATHXQ?
Track your performance easily

Athersys (ATHXQ) Stock Price & Analysis

858 Followers

ATHXQ Stock Chart & Stats


Financials

Annual

Ownership Overview

0.11%<0.01%0.03%99.85%
0.03% Other Institutional Investors
99.85% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

ATHXQ FAQ

What was Athersys’s price range in the past 12 months?
Athersys lowest stock price was <$0.01 and its highest was $0.04 in the past 12 months.
    What is Athersys’s market cap?
    Currently, no data Available
    When is Athersys’s upcoming earnings report date?
    Athersys’s upcoming earnings report date is Nov 11, 2024 which is in 6 days.
      How were Athersys’s earnings last quarter?
      Currently, no data Available
      Is Athersys overvalued?
      According to Wall Street analysts Athersys’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Athersys pay dividends?
        Athersys does not currently pay dividends.
        What is Athersys’s EPS estimate?
        Athersys’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Athersys have?
        Athersys has 61,718,765 shares outstanding.
          What happened to Athersys’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Athersys?
          Currently, no hedge funds are holding shares in ATHXQ
          ---

          Athersys Stock Smart Score

          10
          Unlock Smart Score
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Company Description

          Athersys

          Athersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH.
          ---

          ATHXQ Earnings Call

          Q3 2022
          0:00 / 0:00
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Avalo Therapeutics
          Cyclacel Pharmaceuticals
          Eloxx Pharmaceuticals
          Genprex
          Popular Stocks
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis